Login / Signup

Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.

Yoshikazu NagaseKosuke HiramatsuMasashi FunauchiMayu ShiomiTatsuo MasudaMamoru KakudaSatoshi NakagawaAi MiyoshiShinya MatsuzakiEiji KobayashiToshihiro KimuraSatoshi SeradaYutaka UedaTetsuji NakaTadashi Kimura
Published in: BMC cancer (2022)
Our results suggest that LSR contributes to tumor growth, invasion, metastasis, and poor prognosis of EC through MAPK signaling. Anti-LSR mAb is a potential therapeutic agent for EC.
Keyphrases
  • monoclonal antibody
  • poor prognosis
  • endometrial cancer
  • long non coding rna
  • adipose tissue
  • signaling pathway
  • oxidative stress
  • cell migration
  • pi k akt
  • cell proliferation
  • low density lipoprotein